Submitted on Monday 14th January 2019
Rejected on Thursday 24th January 2019
Current status: Rejected
Rejection code: irrelevant (see below for details)
Make Erenumab available to Migraine sufferers on the NHS
Migraine causes loss of vision, speech, numbness, confusion, sickness, fatigue and pain for up to 72 hrs, its more common than diabetes, epilepsy and asthma. 190,000 attacks daily cause 25 million sick days a year. Aimovig halves attacks, NICE rejected it for NHS use. Private cost £480 a month.
Please visit The Migraine Trust website.
You can't sign this petition because it was rejected. But you can still comment on it here at Repetition.me!
The Government e-Petitions Team gave the following reason:
We can't accept your petition because this is the responsibility of the National Institute for Health and Care Excellence (NICE), not the UK Government or Parliament.
18.221.13.173 Fri, 03 May 2024 02:49:17 +0100
